Experiment to Show the Effect of Titrating MHC class I Tetramer on Non-specific Staining


[Method] [Gating] [Tetramer Dilution Effect] [Elimination of Non-specificity]






Method

The following protocol was used to show the effect of titrating the MHC class I tetramer HLA-A*0201/GILGFVFTL on the amount of non-specific tetramer binding.

Antibodies Used:
Channel Specificity Clone Fluorochrome Vendor Volume
FL1 CD3 B9.11 FITC Immunotech 20ul
FL1 CD3 UGHT1 FITC Immunotech 20ul
FL2 CD3 UGHT1 PE Immunotech 20ul
FL4 CD3 UGHT1 APC Immunotech 10ul

Dilution of Tetramer:

MHC class I tetramer (HLA-A*0201/GILGFVFTL -PE) was diluted in FACS buffer (PBS plus 1% BSA). For the 1:100 dilution (one part tetramer to 100 parts sample, in this case whole blood), 4ul of concentrated tetramer was diluted with 6ul of FACS buffer. Therefore, 4ul of concentrated tetramer was added to 400ul whole blood (see below). Dilutions were made from the diluted tetramer for the 1:300, 1:900, 1:2700 and 1:8100 dilutions

Staining Cells:




Gating

The following two graphs show the gates used in this experiment. The first gate was on the forward versus side plot and captured the lymphocyte population. The second gate was on the foward versus CD3 plot and captured the CD3 positive lymphocyte population.




Tetramer Dilution Effect

The following plots show the effect of titrating the tetramer on the amount of non-specific binding seen in the CD8 negative-Tetramer positive quadrent.




Elimination of Non-specificity

The following graph show the elimination of non-specific staining by the tetramer. The specific staining (tet+, CD8+) shows a gradual reduction of staining with titration of the tetramer, whereas, the non-specific staining (tet+, CD8-) is quickly eliminated.



Overview | General Guidelines | Request Prioritization | Request Form
FAQ | Registration Form | Table of Contents | Contact Us!


Last updated September 3, 2005